Results

Total Results: 398 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

81. Final Evidence Summary: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/cognitive-impairment-in-older-adults-screening
    February 25, 2020 - planning, including advance directives; safety planning; legal and financial planning); patient health … Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia … The efficacy and safety of donepezil in patients with Alzheimer’s disease: results of a US multicentre … Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled … Efficacy and safety of galantamine in patients with mild to moderate Alzheimer’s disease: multicentre

82. Archived: Obesity: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-screening-1996
    January 01, 1996 - Influence of weight reduction on plasma lipoproteins in obese patients. … Weight loss in mildly to moderately obese patients with obstructive sleep apnea. … Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture … Efficacy and safety of dexfenfluramine in obese patients: multi-centre study. … Gastric surgery in morbid obesity: outcome in patients aged 55 years and older.

83. Evidence Summary: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
    May 02, 2023 - [95% CI, 1.01-1.75]). 138 Rifampin Compared With Isoniazid Four open-label RCTs and 1 post hoc safety … Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection … TB according to patient age. … events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety

84. Archived: Depression in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-in-adults-screening-2009
    December 15, 2009 - There may be considerations that support screening for depression in an individual patient. … ; an initial visit with a nurse specialist for assessment, education, and discussion of patient preferences … , preventive and health maintenance interventions take place" to improve the quality and outcome of patient … Finally, additional information is needed about the efficacy, tolerability, and safety of antidepressants … The case manager also provided patient education and follow-up.

85. Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/impaired-visual-acuity-screening-older-adults
    May 24, 2022 - Data Abstraction and Quality Rating One investigator abstracted details about the study design, patient … Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two … Utility of a patient-response screening question for visual impairment. … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … = .25 Bilateral visual impairment: 35% vs 47%;  P = .17 Abbreviations: ACCS, Aged Care Client

86. Screening for Hepatitis C Virus Infection in Adolescents and Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/WEqCV3NvnZAeLdC_pp6nVK
    October 01, 2018 - Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 … Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis … Efficacy and safety of ombitasvir, paritaprevir, and ritonavir in an open-label study of patients with … Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis … Sofosbuvir and velpatasvir combination improves patient-reported outcomes for patients with HCV infection

87. Final Evidence Summary: Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/other-supporting-document19727/drug-use-illicit-primary-care-interventions-for-children-and-adolescents
    September 03, 2020 - Other interventions demonstrated beneficial effects only for some patient subgroups, including 2 primary … Key Substance Use and Mental Health Indicators in the United States: Results From the 2016 National Survey … Missed opportunity: national survey of primary care physicians and patients on substance abuse. … https://www.centeronaddiction.org/addiction-research/reports/national-survey-primary-care-physicians-patients-substance-abuse … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety

88. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
    June 20, 2019 - professional judgment and patient preferences. … Offer or provide this service for selected patients depending on individual circumstances. … PDQ Breast Cancer Prevention (PDQ®)—Patient Version. … Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation. … Safety assessment of raloxifene over eight years in a clinical trial setting.

89. Evidence Summary: Hypertension in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hypertension-in-adults-screening
    April 27, 2021 - Confirmatory methods examined in KQ3 included repeated OBPM, self-OBPM (measurement performed by a patient … 57 , 65 , 81 , 88 , 90 , 99 As in KQ2, most OBPM confirmatory measurements were obtained with the patient … Effects of labeling patients as prehypertensive. … Blood pressure-lowering treatment based on cardiovascular risk: ameta-analysis of individual patient … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety

90. Evidence Summary: Skin Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/skin-cancer-screening
    April 18, 2023 - Studies of patient skin self-examination were excluded because this topic is covered in the 2018 USPSTF … Overdiagnosis can result in overtreatment that may not benefit the patient. 14 Data Extraction and … Studies used large databases with patient information from the US (SEER [Surveillance, Epidemiology, … Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease … questions (KQs) that the review will address to allow the USPSTF to evaluate the effectiveness and safety

91. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2013
    September 15, 2013 - (USPSTF) makes recommendations about the effectiveness of specific clinical preventive services for patients … benefits of risk-reducing medications could outweigh potential risks, clinicians should first identify patients … Clinicians should then strive to ensure that patients make a fully informed decision that incorporates … Clinical trials that provide more information about the safety and effectiveness of other medications … Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.

92. Archived: Evidence Summary: Preeclampsia: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/preeclampsia-screening-april-2017
    April 25, 2017 - derivation study, assessing either performance or effect) multivariable risk prediction models using patient … Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … h A test performance statistic used to measure what proportion of patients who test positive have the … i A test performance statistic used to measure what proportion of patients who test negative do not

93. PII: S0749-3797(01)00255-0 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
    January 01, 2001 - The safety experience for bile-acid binding resins and niacin, however, is based on a longer period of … Analytical quality of near-patient blood cholesterol and glucose determinations. … Int J Risk Safety Med 1990;1:29–44. 30. Havas S, Reisman J, Hsu L, Koumjian L. … Safety of treatment, changes in risk factors, and incidence of coronary heart disease. … Efficacy and safety of pravastatin in African Americans with primary hypercholesterolemia.

94. Archived: Evidence Summary: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
    April 09, 2001 - The safety experience for bile-acid binding resins and niacin, however, is based on a longer period of … Analytical quality of near-patient blood cholesterol and glucose determinations. … Int J Risk Safety Med 1990;1:29–44. 30. Havas S, Reisman J, Hsu L, Koumjian L. … Safety of treatment, changes in risk factors, and incidence of coronary heart disease. … Efficacy and safety of pravastatin in African Americans with primary hypercholesterolemia.

95. Evaluating Primary Care Behavioral Counseling Interventions: An Evidence-based Approach (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/behavintr.pdf
    January 01, 2010 - Healthy People 2010 leading health indicators* * Other leading health indicators include mental health … intervention, such as general promotion of physical activity in the presence of recent morbidity96 or the safety … importance of adjusting behavior change plans to the culture, social circumstances, and economic status of clients … Smoking cessation: Recent indicators of what’s working at a population level. … Preferences of patients for patient centered approach to consultation in primary care: Observational

96. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients … As with all of its recommendations, the USPSTF encourages clinicians to discuss with patients the risks … PDQ Breast Cancer Prevention (PDQ®)—Patient Version. NCI website. … Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation. … Safety assessment of raloxifene over eight years in a clinical trial setting.

97. Evidence Summary: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
    September 28, 2021 - evidence, including study design and setting, internal validity, and important characteristics about patients … A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow. … Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. … questions (KQs) that the review will address to allow the USPSTF to evaluate the effectiveness and safety … risk determined by clinician based on range of factors including obstetric history, family history, patient

98. Archived: Family Violence: Screening and Interventions, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/family-violence-screening-interventions-1996
    January 01, 1996 - The value of the patient interview may be limited if the abuser is present. … elder abuse as part of the periodic health examination, but recommended that physicians be alert for indicators … The safety of children of victims of abuse should also be ensured.  … Abuse of patients in nursing homes: findings from a survey of staff. … Laws mandating reporting of domestic violence: do they promote patient well-being?

99. Archived: Evidence Summary (Pregnant and Postpartum Women): Screening for Depression in Adults | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-primary-care-screening-for-and-treatment-of/depression-in-adults-screening
    January 26, 2016 - Data were sparse for Patient Health Questionnaire instruments. … but acknowledged there may be considerations that support screening for depression in an individual patient … For diagnostic accuracy (KQ2), we examined studies of the Patient Health Questionnaire (PHQ) or Edinburgh … Trials had to use population-based screening to identify eligible patients. … Efficacy and Safety of Screening for Postpartum Depression.

100. Interventions for Weight Management in Children and Adolescents: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/e9f8a_uGMXxSbBUxpRPkrc
     June 18, 2024 - Editorial Multimedia Related article and JAMA Patient Page Supplemental content CME at jamacmelookup.com … questions that the review will address in order to allow the USPSTF to evaluate the effectiveness and safety … adolescent population with obesity: a randomized, double-blind, placebo-controlled 5-week trial to assess safety … placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics … Impact of weight bias and stigma on quality of care and outcomes for patients with obesity.